Thinking about getting pregnant while taking Mounjaro

You're planning ahead, and that's exactly the right time to ask

Picture this: you've been on Mounjaro for a few months, the pen lives in the fridge door next to the milk, your routine is settled, and you're starting to think seriously about trying for a baby. The question feels urgent because the medicine is working and stopping it is a real prospect, not an abstract one.

The honest answer is that Mounjaro has not been studied in human pregnancies. Because animal studies showed effects on foetal development at certain doses, the licensed UK prescribing information (the Mounjaro SmPC, available on the electronic medicines compendium) advises against use during pregnancy. That precaution exists precisely because there is not yet human safety data to reassure prescribers otherwise. Absence of evidence is not the same as evidence of safety, and with something as significant as a pregnancy, UK regulators have taken the cautious position. The NHS guidance on weight-management injections echoes this directly.

So if you are currently on Mounjaro and thinking about conceiving in the coming months, the right step is to raise it with your prescriber now rather than waiting until you're already trying. There will be a wash-out period to plan for, your prescriber will advise on the specific timeframe based on your situation. Starting that conversation early means the timing is yours to manage.

The contraceptive pill and Mounjaro: a detail many people miss

Mounjaro slows gastric emptying, that's part of how it reduces appetite. The same mechanism, however, can affect how quickly your body absorbs an oral contraceptive pill. If absorption is delayed or reduced, the pill may not work as reliably as it should.

NHS guidance is specific on this: for the first four weeks of Mounjaro treatment, and for four weeks after every dose increase, women using oral contraceptives should add a non-oral method of contraception alongside the pill. A condom is the practical option most people reach for. After those four weeks at a stable dose have passed, you can return to the pill alone, until the next dose step, when the four-week window restarts.

This matters whether you want to avoid pregnancy or plan for one. If you are actively trying to conceive, the picture changes entirely: Mounjaro should be stopped before you start trying, not continued with extra contraception. The two goals are not compatible at the same time. You can read more about how tirzepatide works in the body on our tirzepatide overview.

There is no equivalent pill-interaction warning for semaglutide, according to current NHS guidance, though all GLP-1 medicines carry the same recommendation against use in pregnancy itself.

If you discover you're pregnant while still on treatment

Unplanned pregnancies happen, including to people who did not realise their contraception was less effective than expected. If you discover you are pregnant while taking Mounjaro, stop the injections straight away and contact your GP or midwife as soon as possible. Do not wait for your next prescription review or your next scheduled check-in.

The MHRA encourages reporting of any suspected side effects or pregnancy exposures through the Yellow Card scheme, this kind of real-world data matters for building the safety picture over time. Your GP can also make a report through the same route.

There is no need to panic. The guidance to stop is precautionary, not because exposure is known to cause a specific harm at the doses used in weight management. But it is still important to act quickly, be open with your maternity team, and give them the full picture so your care can be appropriately monitored.

If you have broader questions about managing weight before or after pregnancy without medication, the NHS healthy weight guidance is a reliable starting point. And when the time comes to think about returning to treatment after pregnancy and breastfeeding, a fresh clinical assessment will be needed, as it would be for any new prescription.

HRT, transdermal options and the wider picture for women on Mounjaro

For women taking hormone replacement therapy alongside Mounjaro, NHS England has flagged a similar absorption consideration: oral HRT formulations may also be affected by Mounjaro's gastric-emptying effect. The clinical guidance suggests considering transdermal forms (patches or gels applied to the skin) which bypass the gut entirely and are not subject to the same absorption variable. This is worth discussing with your GP if you are on oral HRT and starting tirzepatide.

The broader point is that Mounjaro is a potent medicine that interacts with several common treatments, not just the contraceptive pill. Before starting or changing anything (whether contraception, HRT or another prescription) the right move is to talk to a prescriber who knows your full medical history. Our clinical team reviews every consultation personally, and questions like these are exactly what that review is designed to catch. You can also explore our frequently asked questions for general guidance on managing treatment, including practical details such as how to use the swabs that come with your Mounjaro kit, or see our Mounjaro overview page for a broader look at the medicine.

If you have already been on Mounjaro for some time and are weighing up costs as part of your longer-term planning, our Mounjaro cost page sets out what private treatment typically involves. And if the time does come to pause treatment and later restart, understanding what weight-loss treatment looks like as a process, including whether cravings for sugar shift as your body adjusts to tirzepatide, will help you plan realistically.

When you are ready to discuss your own circumstances with a prescriber, you can check your eligibility through a free consultation, no waiting list, no automated triage. If you are also comparing options and want to understand how the en version of Mounjaro differs from other available formats, that information is available to read through before your consultation.